Frontlight ResearchEarly access
Trial site
Woolloongabba
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Stroke3 trials
- Familial hypercholesterolaemia2 trials
- IgA nephropathy2 trials
- Chronic kidney disease1 trial
- Lung cancer1 trial
- Multiple sclerosis1 trial
- Phase
- Phase 38 trials
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Lead sponsor
- Novartis Pharmaceuticals8 trials
Running trials
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting
Closed trials
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026